Interpace Biosciences

$4.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.38 (+10.12%) Today
-$0.08 (-1.96%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IDXG and other stocks, options, and ETFs commission-free!

About IDXG

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. Read More The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ. The listed name for IDXG is Interpace Biosciences, Inc. Common Stock.

Employees
178
Headquarters
Parsippany, New Jersey
Founded
1986
Market Cap
16.49M
Price-Earnings Ratio
Dividend Yield
Average Volume
5.33M
High Today
$4.20
Low Today
$3.69
Open Price
$3.81
Volume
279.15K
52 Week High
$11.00
52 Week Low
$2.57

Collections

IDXG Earnings

-$2.31
-$1.54
-$0.77
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
-$1.48 per share
Actual
-$1.35 per share

You May Also Like